Glycorex Transplantation logo

Glycorex Transplantation Investor Relations Material

Glycorex Transplantation AB is a Swedish biotechnology company headquartered in Uppsala. It owns GlycoMab, a patented technology used to create antibodies that are immunosuppressive drugs like Atgam, which the company produces. The company also collaborates with third-party companies for the development and commercialization of other therapies

Upcoming events for

Q2 20222022-08-26

Latest company events

Ticker symbol

GTAB

Country

Sweden

About the company

https://glycorex.com/sv/

Dig deeper into the Glycorex Transplantation fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot